Our analysis showed that the expression level of UGT2B4 in tumors of breast cancer was significantly lower than normal tissues (Supplementary Figure S3) while UGT2B4 was significantly higher in tumors than normal tissues of prostate cancer (Figure 5A). Here, UGT2B4 is linked to prostate carcinoma.